Q fever pathophysiology: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
Line 6: Line 6:
   
   
==Pathophysiology==
==Pathophysiology==
===Transmission:===
The organism is transmitted through:
*Aerosoloes: Inhalation of contaminated aerosoles is the main mode of transmission.
*Ingestion of raw dairy products
*Vertical (mother to fetus) transmission has been reported
*Parentral
*(Through tick bites
===Pathogenesis:===
C. Brutenii has the ability to exist in 2 forms:
Small cell form:
Often described as the spore form of C. Brutenii
Resists the external environmental factors as heat, pressure and dissinfectants for long periods
Large cell form:
The active form of the organism
Large cell form persists in the macrophages inside acidic vacuoles.
Small and large cell forms are antigenically different and this plays a role in the virulence of the organism.
The genome of C. Brutenii has been analysed in 1995. Multiple genes encoding for Na/ ion proton exchanger have been discovered and this explains the ability of the organism to survive in low PH.
The infection has 2 phases that correlate with changes in the lipopolysaccharide of C. Brutenii.
Phase I: characterized by smooth lipopolysacharide capsule. Despite being less efficient in invasion of host cells, antibodies against phase I is always isolated  from acute Q fever patients.
Phase II: characterized by rough lipopolysacharide capsule and antibodies against phase II have been isolated from chronic Q fever patients.
Q fever as a biological weapon:
C. Brutenii is an extremely virulent organism.
According to WHO estimates, an amount of 50 kg of  C. Brutenii if spread in an area of 2 square kilometers is capable of:
*Infecting 500,000 humans
*Killing 150 individuals
*Causing acute illness in 125,000 individuals
*Causing chronic illness in 9,000 individuals
Microscopic pathology:
*C. Brutenii is a gram negative polymorphic intracellular organism.
*It was previously classified as a ricketsia, but now is considered a proteobacterium.


{| style="float: right; width: 350px;"
| [[Image:Coxiella burnetii.JPG|right|300px|C. burnetii, the Q fever causing agent]]
|}
* Cattle, sheep, and goats are the primary reservoirs of [[Coxiella burnetii|C. burnetii]].  The infection has been noted in a wide variety of other animals, including other species of livestock and in domesticated pets.
* [[Coxiella burnetii]] does not usually cause clinical disease in these animals, although abortion in goats and sheep has been linked to C. burnetii infection. 
* [[Organisms]] are excreted in milk, urine, and feces of infected animals. Most importantly, during birthing, the organisms are shed in high numbers within the [[Amniotic fluid|amniotic fluids]] and the placenta. 
* The [[organisms]] are resistant to heat, drying, and many common disinfectants.  These features enable the [[bacteria]] to survive for long periods in the environment. 
* Infection of humans usually occurs by inhalation of these [[organisms]] from the air that contains airborne barnyard dust contaminated by dried placental material, birth fluids, and excreta of infected herd animals. 
* Humans are often very susceptible to the disease, and very few [[organisms]] may be required to cause infection.  Ingestion of contaminated milk, followed by regurgitation and inspiration of the contaminated food, is a less common mode of transmission. 
* Other modes of transmission to humans, including [[tick bites]] and human to human transmission, are rare.


==References==
==References==

Revision as of 15:54, 6 June 2017

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Q fever Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Q fever from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications, and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Chest X Ray

CT

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary prevention

Secondary prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Q fever pathophysiology On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Q fever pathophysiology

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Q fever pathophysiology

CDC on Q fever pathophysiology

Q fever pathophysiology in the news

Blogs on Q fever pathophysiology

Directions to Hospitals Treating Q fever

Risk calculators and risk factors for Q fever pathophysiology

Overview

Pathophysiology

Transmission:

The organism is transmitted through:

  • Aerosoloes: Inhalation of contaminated aerosoles is the main mode of transmission.
  • Ingestion of raw dairy products
  • Vertical (mother to fetus) transmission has been reported
  • Parentral
  • (Through tick bites

Pathogenesis:

C. Brutenii has the ability to exist in 2 forms:

Small cell form: Often described as the spore form of C. Brutenii Resists the external environmental factors as heat, pressure and dissinfectants for long periods

Large cell form: The active form of the organism Large cell form persists in the macrophages inside acidic vacuoles.

Small and large cell forms are antigenically different and this plays a role in the virulence of the organism. The genome of C. Brutenii has been analysed in 1995. Multiple genes encoding for Na/ ion proton exchanger have been discovered and this explains the ability of the organism to survive in low PH.

The infection has 2 phases that correlate with changes in the lipopolysaccharide of C. Brutenii.

Phase I: characterized by smooth lipopolysacharide capsule. Despite being less efficient in invasion of host cells, antibodies against phase I is always isolated from acute Q fever patients.

Phase II: characterized by rough lipopolysacharide capsule and antibodies against phase II have been isolated from chronic Q fever patients.

Q fever as a biological weapon:

C. Brutenii is an extremely virulent organism. According to WHO estimates, an amount of 50 kg of C. Brutenii if spread in an area of 2 square kilometers is capable of:

  • Infecting 500,000 humans
  • Killing 150 individuals
  • Causing acute illness in 125,000 individuals
  • Causing chronic illness in 9,000 individuals

Microscopic pathology:

  • C. Brutenii is a gram negative polymorphic intracellular organism.
  • It was previously classified as a ricketsia, but now is considered a proteobacterium.


References


Template:WikiDoc Sources